Gemphire Therapeutics Inc. Contracts & Agreements

141 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Pre-Funded Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Securities Purchase Agreement, dated as of May 8, 2025, by and among the Company and the Purchasers identified on the signature pages thereto
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Placement Agency Agreement, dated as of May 8, 2025 by and between the Company and the Placement Agent
Gemphire Therapeutics Inc.
Biotechnology
2025
Registration Rights Agreement, dated as of May 8, 2025, by and among the Company and the Purchasers identified on the signature pages thereto
Gemphire Therapeutics Inc.
Biotechnology
2025
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2025
Form of Indemnification Agreement
Indemnification Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
2019 Equity Incentive Plan of the Registrant and forms of award agreements
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Amended and Restated 2021 Inducement Plan of the Registrant and form of award agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Amended and Restated 2022 Equity Incentive Plan of the Registrant, as amended November 29, 2024, and forms of award agreements
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Amended and Restated Non-Employee Director Compensation Policy, dated May 7, 2024, as amended November 29, 2024
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2025
Form of Pre-Funded Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Form of Series A Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Form of Series B Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Form of Placement Agent Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Form of Securities Purchase Agreement, dated as of June 23, 2024, by and among the Company and the Purchaser identified on the signature page thereto
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2024
Form of Securities Purchase Agreement, dated as of June 23, 2024, by and among the Company and the Purchasers identified on the signature pages thereto
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2024
Form of Registration Rights Agreement, dated as of June 23, 2024, by and among the Company and the Purchasers identified on the signature pages thereto
Registration Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
First Amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of June 7, 2024
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Amended and Restated Non-Employee Director Compensation Policy, dated May 7, 2024
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Employment Agreement entered into on March 1, 2024 by and between NeuroBo Pharmaceuticals, Inc. and Marshall H. Woodworth
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2024
Lease Agreement, dated as of August 23, 2023, by and between Alewife Properties LLC and NeuroBo Pharmaceuticals, Inc
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2023
Employment Agreement entered into on August 11, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Hyung Heon Kim
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2023
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2023
Amendment to Dong-A Series A Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2023
Amendment to Dong-A Series B Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2023
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2023
Amendment to Membership Agreement, dated December 14, 2022 by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2023
Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2023
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of December 22, 2022
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan Forms of Option Grant Agreements
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
Amendment to Membership Agreement, dated August 30, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Underwriting Agreement dated as of November 4, 2022, by and between NeuroBo Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc
Underwriting Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
Form of Series A Warrant to purchase shares of common stock
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Series B Warrant to purchase shares of common stock
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Warrant Agency Agreement
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Dong-A Series A Warrant to purchase shares of common stock
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Dong-A Series B Warrant to purchase shares of common stock
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc
Underwriting Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
Form of Series A Warrant offered hereby
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Series B Warrant offered hereby
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Leak-Out Agreement
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Voting Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman
Voting Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Lock-Up Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Voting Agreement to be executed by entities affiliated with E&Investment, Inc
Voting Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Lock-Up Agreement to be executed by entities affiliated with E&Investment, Inc
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc
Underwriting Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
Form of Warrant Agency Agreement between the Registrant and American Stock Transfer & Trust Company
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Form of Warrant offered hereby
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
License Agreement, between by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022
License Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Shared Services Agreement, between by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022
Services Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Securities Purchase Agreement, by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Registration Rights Agreement, by and among Dong-A ST Co., Ltd., The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6, The E&Healthcare Investment Fund No....
Registration Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Investor Rights Agreement, by and between Dong-A ST Co. Ltd. and the Company, dated September 14, 2022
Investor Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated April 19, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated December 23, 2021, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated February 9, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan
Stock Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2021
Employment Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Warrant to purchase shares of common stock
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2021
Form of Securities Purchase Agreement, dated as of October 1, 2021, by and among NeuroBo Pharmaceuticals, Inc. and the purchasers identified on the signature pagers thereto
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2021
RELEASE AGREEMENT
Release Agreements
Gemphire Therapeutics Inc.
Biotechnology
CA
2021
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated May 14, 2021
Gemphire Therapeutics Inc.
Biotechnology
2021
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2021
Employment Agreement, dated as of December 31, 2020, by and between the Registrant and Akash Bakshi
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
First Amendment to Contingent Value Rights Agreement, dated as of December 30, 2019, by and among NeuroBo, the Holders Representative, and the Rights Agent, dated as of March 23,...
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2021
Form of Securities Purchase Agreement
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2021
Form of Registration Rights Agreement
Registration Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
2021
Agreement and Plan of Merger, dated December 31, 2020, by and among NeuroBo Pharmaceuticals, Inc., Shelby Merger Sub 1, Inc., Shelby Merger Sub 2, LLC, ANA Therapeutics, Inc., and...
Merger Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Support Agreement
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Lock-Up Agreement
Gemphire Therapeutics Inc.
Biotechnology
2021
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated November 11, 2020
Gemphire Therapeutics Inc.
Biotechnology
2020
Dong-A ST CO., LTD. Manufacturing and Supply Agreement (NB-02 formerly DA-9803) dated June 7, 2020
Supply Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2020
Form of Placement Agents Warrant
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
2020
Form of Securities Purchase Agreement
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2020
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2020
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated January 9, 2020
Gemphire Therapeutics Inc.
Biotechnology
NY
2020
Offer Letter, dated as of January 29, 2020, by and between Nicola Shannon and NeuroBo Pharmaceuticals, Inc
Gemphire Therapeutics Inc.
Biotechnology
2020
Form of Incentive Stock Option Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Restricted Stock Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Non-Qualified Stock Option Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Stock Unit Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Employment Agreement, dated February 11, 2020, by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MD
2020
Contingent Value Rights Agreement, dated as of December 30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare Inc. and Computershare Trust...
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated May 1, 2018 and extension of such agreement,...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
Offer Letter, dated as of August 20, 2018, by and between Nicola Shannon and NeuroBo
Gemphire Therapeutics Inc.
Biotechnology
2019
Form of Indemnification Agreement between NeuroBo Pharmaceuticals, Inc. and each of its directors and executive officers
Indemnification Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
First Amendment to Agreement and Plan of Merger and Reorganization, dated as of October 29, 2019, by and among Gemphire, Merger Sub and NeuroBo
Merger Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Steven Gullans dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Charles L. Bisgaier dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Seth Reno dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Lease Agreement by and between Invest Korea Plaza and NeuroBo Co., Ltd., dated February 21, 2018
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Lease Agreement by and between Business District and NeuroBo Pharmaceuticals, Inc., dated April 19, 2018, and Addendum Nos. 1, 2 and 3 entered into thereunder
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Manufacturing and Supply Agreement between Dong-A ST Co., Lt. and NeuroBo Pharmaceuticals, Inc., dated September 28, 2018
Supply Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2019
Consulting Agreement by and between Healthcare Capital LLC, owned and managed entirely by John L. Brooks III and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement Consulting...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
Independent Contractor Agreement by and between Therabo PLLC and NeuroBo Pharmaceuticals, Inc., dated March 1, 2019
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
Lease Agreement by and between Gyeonggi Urban Innovation Corporation and NeuroBo Co., Ltd., dated May 2, 2019
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Fourth Amended and Restated Stockholders' Agreement, by and among the Initial Holders and the Investors on Schedule A thereto and NeuroBo Pharmaceuticals, Inc., dated May 30, 2019
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
License Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019
License Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2019
Acquisition Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
2018 Stock Plan for NeuroBo Pharmaceuticals, Inc
Stock Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Form of Stock Option Agreement for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan
Stock Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Form of Notice of Grant of Restricted Stock Purchase Right for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan
Stock Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Form of Notice of Grant of Stock Option for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan
Stock Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Form of Notice of Grant of Restricted Stock Bonus for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
First Amendment to Employment Agreement dated as of July 24, 2019 by and between Gemphire and Steve Gullans
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Acknowledgement of Lease Commencement between North Laurel Project, LLC and Gemphire Therapeutics Inc. dated August 26, 2016
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Employment Agreement by and between the Registrant and Seth Reno
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Separation and Release Agreement with Jeffrey S. Mathiesen dated as of September 21, 2018
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2018
Separation and Release Agreement with Dr. Lee Golden dated as of September 21, 2018
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2018
Amended and Restated License Agreement effective August 2, 2018 by and between Gemphire Therapeutics Inc. and Pfizer Inc
License Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2018
Warrant to Purchase Stock, dated July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2018
First Amendment to Loan and Security Agreement, dated as of July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank
Loan Agreements
Gemphire Therapeutics Inc.
Biotechnology
2018
AMENDMENT TO THE GEMPHIRE THERAPEUTICS INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: April 9, 2018 APPROVED BY THE STOCKHOLDERS: May 22,...
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2018
Employment Agreement
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2018
AMENDMENT No. 1 TO THE Gemphire Therapeutics Inc. INDUCEMENT PLAN
Gemphire Therapeutics Inc.
Biotechnology
2018
3,142,858 Shares Gemphire Therapeutics Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2018
Separation and Release Agreement between Gemphire Therapeutics Inc. and Mina Sooch dated May 30, 2017
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2017
Offer Letter between Gemphire Therapeutics Inc. and Dr. Steve Gullans dated June 8, 2017
Gemphire Therapeutics Inc.
Biotechnology
2017
LOAN AND SECURITY AGREEMENT
Loan Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2017
GEMPHIRE THERAPEUTICS INC. FORM OF WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2017
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
2017
GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN APPROVED BY THE BOARD OF DIRECTORS ON: September 30, 2016
Gemphire Therapeutics Inc.
Biotechnology
DE
2016
GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN OPTION GRANT NOTICE
Gemphire Therapeutics Inc.
Biotechnology
2016
[] Shares Gemphire Therapeutics Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2016
GEMPHIRE THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2016
INDEMNIFICATION AGREEMENT Effective Date: , 2016
Indemnification Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2016
GEMPHIRE THERAPEUTICS INC. 2015 EQUITY INCENTIVE PLAN APPROVED BY THE BOARD OF DIRECTORS: April 28, 2015 APPROVED BY THE STOCKHOLDERS: April 28, 2015
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
OFFICE SPACE SUBLEASE AGREEMENT
Lease Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2016
FORM OF NOTE PURCHASE AGREEMENT
Note Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2016
GEMPHIRE THERAPEUTICS INC. FORM OF NOTE PURCHASE AGREEMENT JOINDER AGREEMENT
Note Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016